Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
BlueLinx
BXC
$430M
| $195K | ﹤0.01% |
+22,812
| New | +$141K |
|
3802
Ocular Therapeutix
OCUL
$1.83B
| $195K | ﹤0.01% |
23,437
-992,639
| -98% | -$6.58M |
|
3803
Western New England Bancorp
WNEB
$259M
| $194K | ﹤0.01% |
+33,505
| New | +$186K |
|
|
TBHC
3804
DELISTED
The Brand House Collective
TBHC
| $193K | ﹤0.01% |
71,094
-252,361
| -78% | -$312K |
|
|
CKPT
3805
DELISTED
Checkpoint Therapeutics
CKPT
| $190K | ﹤0.01% |
9,612
+5,208
| +118% | +$94.9K |
|
|
PFC
3806
DELISTED
Premier Financial Corp. Common Stock
PFC
| $190K | ﹤0.01% |
10,725
-102,323
| -91% | -$1.66M |
|
3807
Natural Health Trends
NHTC
$14.8M
| $189K | ﹤0.01% |
33,083
-15,499
| -32% | -$80.2K |
|
|
WLL
3808
DELISTED
Whiting Petroleum Corporation
WLL
| $189K | ﹤0.01% |
2,233
-4,386
| -66% | -$342K |
|
|
GCAP
3809
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $188K | ﹤0.01% |
31,204
+18,312
| +142% | +$113K |
|
|
GNCA
3810
DELISTED
Genocea Biosciences, Inc.
GNCA
| $187K | ﹤0.01% |
81,385
+68,664
| +540% | +$158K |
|
3811
OFG Bancorp
OFG
$2.21B
| $186K | ﹤0.01% |
13,879
-165,573
| -92% | -$2M |
|
3812
DHI Group
DHX
$177M
| $183K | ﹤0.01% |
87,277
-125,169
| -59% | -$322K |
|
|
JFIN
3813
Jiayin Group
JFIN
$115M
| $182K | ﹤0.01% |
+46,520
| New | +$132K |
|
3814
Target Hospitality
TH
$1.43B
| $182K | ﹤0.01% |
+107,437
| New | +$208K |
|
3815
Natural Gas Services Group
NGS
$457M
| $181K | ﹤0.01% |
28,853
+13,466
| +88% | +$78.1K |
|
3816
iShares MSCI Europe Financials ETF
EUFN
$4B
| $180K | ﹤0.01% |
+12,626
| New | +$167K |
|
3817
Nature's Sunshine
NATR
$362M
| $180K | ﹤0.01% |
+19,956
| New | +$173K |
|
|
PRGX
3818
DELISTED
PRGX Global, Inc.
PRGX
| $180K | ﹤0.01% |
38,293
+8,638
| +29% | +$31K |
|
|
RJET
3819
Republic Airways Holdings
RJET
$845M
| $179K | ﹤0.01% |
+3,477
| New | +$184K |
|
|
NGD
3820
DELISTED
New Gold Inc
NGD
| $179K | ﹤0.01% |
132,346
+62,594
| +90% | +$62.8K |
|
3821
DNA X Inc
SONM
$4.63M
| $178K | ﹤0.01% |
+122
| New | +$195K |
|
|
ONCT
3822
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $178K | ﹤0.01% |
3,128
-136
| -4% | -$7.67K |
|
|
LAC
3823
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $178K | ﹤0.01% |
35,169
+4,373
| +14% | +$16.3K |
|
|
ACH
3824
DELISTED
Alum Corp of China Ltd
ACH
| $177K | ﹤0.01% |
+37,669
| New | +$188K |
|
3825
Adeia
ADEA
$2.55B
| $175K | ﹤0.01% |
44,725
-225,730
| -83% | -$854K |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.